Kuros Biosciences Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
8.6 M |
Public Float |
- |
Kuros Biosciences Ltd. | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF1.3 |
Market Cap |
CHF26.74 M |
Shares Outstanding |
15.06 M |
Public Float |
10.09 M |
Address |
Wagistrasse 25 Schlieren Zurich 8952 Switzerland |
Employees | - |
Website | http://www.kurosbiosciences.com |
Updated | 07/08/2019 |
Kuros Biosciences Ltd. engages in the development of products for tissue repair and regeneration. Its products include sealants for tissue restore and orthobiologics for bone healing. The company was founded by Didier Cowling and Jason Schense in 2000 and is headquartered in Schlieren, Switzerland. |